These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 36824028)

  • 1. Metal Complexes in Cancer Treatment: Journey So Far.
    Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
    Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
    Abid M; Shamsi F; Azam A
    Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noble metal-dithiocarbamates precious allies in the fight against cancer.
    Nagy EM; Ronconi L; Nardon C; Fregona D
    Mini Rev Med Chem; 2012 Oct; 12(12):1216-29. PubMed ID: 22931593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New applications of old metal-binding drugs in the treatment of human cancer.
    Schmitt SM; Frezza M; Dou QP
    Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-based Complexes as Potential Anti-cancer Agents.
    Banerjee S; Banerjee S
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2684-2707. PubMed ID: 35362388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
    Nardon C; Brustolin L; Fregona D
    Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy.
    Liu J; Lai H; Xiong Z; Chen B; Chen T
    Chem Commun (Camb); 2019 Aug; 55(67):9904-9914. PubMed ID: 31360938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphoroorganic Metal Complexes in Therapeutics.
    Demkowicz S; Kozak W; Daśko M; Rachon J
    Mini Rev Med Chem; 2016; 16(17):1359-1373. PubMed ID: 27145849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
    Thota S
    Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
    [No Abstract]   [Full Text] [Related]  

  • 13. Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.
    Notaro A; Gasser G
    Chem Soc Rev; 2017 Nov; 46(23):7317-7337. PubMed ID: 29027562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
    Morais TS; Valente A; Tomaz AI; Marques F; Garcia MH
    Future Med Chem; 2016 Apr; 8(5):527-44. PubMed ID: 27096164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.
    Wang K; Gao E
    Anticancer Agents Med Chem; 2014 Jan; 14(1):147-69. PubMed ID: 23869783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal complexes as DNA intercalators.
    Liu HK; Sadler PJ
    Acc Chem Res; 2011 May; 44(5):349-59. PubMed ID: 21446672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal complexes in cancer therapy - an update from drug design perspective.
    Ndagi U; Mhlongo N; Soliman ME
    Drug Des Devel Ther; 2017; 11():599-616. PubMed ID: 28424538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances on Dark and Light-Activated Cytotoxity of Imidazole-Containing Ruthenium Complexes.
    Liu P; Jia J; Zhao Y; Wang KZ
    Mini Rev Med Chem; 2016; 16(4):272-89. PubMed ID: 26586123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.
    Biersack B
    Mini Rev Med Chem; 2016; 16(10):804-14. PubMed ID: 27161009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.